ArticlePathogens (Basel, Switzerland)2025

Efficacy and Safety of Sotrovimab Versus Oral Antiviral for Early Treatment in High-Risk Patients in Omicron Era: A Multicenter Retrospective Study.

Antonio Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.